Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 441471Generated: October 25, 2026

2-Phenylethyl chloroformate → tetrahydro-1-(5-t-butyl-1,3,4-thiadiazol-2-yl)-3-methyl-6-phenethyloxycarbonyloxy-2(1H)-pyrimidinone

https://huagongshe.com/reaction/441471

Reaction equation

Participants

RoleNameHCIDCharge
Reactant2-Phenylethyl chloroformateHCID 15917590—
Reactanttetrahydro-1-(5-t-butyl-1,3,4-thiadiazol-2-yl)-3-methyl-6-hydroxy-2(1H)-pyrimidinoneHCID 21400082—
SolventPyridineHCID 1049—
Producttetrahydro-1-(5-t-butyl-1,3,4-thiadiazol-2-yl)-3-methyl-6-phenethyloxycarbonyloxy-2(1H)-pyrimidinoneHCID 21418678—

Reaction Steps

Tetrahydro-1-(5-t-butyl-1,3,4-thiadiazol-2-yl)-3-methyl-6-hydroxy-2(1H)-pyrimidinone (0.05 mole) dissolved in pyridine (80 ml) is charged into a glass reaction vessel equipped with a mechanical stirrer and themometer. The solution is cooled to a temperature of about 10° C. and phenethyl chloroformate (0.06 mole) dissolved in pyridine (25 ml) is slowly added with stirring over a period of about 15 minutes. After the addition is completed, the reaction mixture is warmed to room temperature and is stirred for an additional period of about 20 minutes to ensure completion of the reaction. After this time the reaction mixture is filtered. The filtrate is then combined with water (100 ml) resulting in the formation of a precipitate. This precipitate is recovered by filtration and is dissolved in ether. The ether solution is washed with dilute aqueous sodium carbonate, is dried over anhydrous magnesium sulfate and is filtered. The filtrate is then stripped of ether to yield the desired product tetrahydro-1-(5-t-butyl-1,3,4-thiadiazol-2-yl)-3-methyl-6-phenethyloxycarbonyloxy-2(1H)-pyrimidinone as the residue.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS04040812
Source datasetuspto-grants-1977_08
ORD IDord-5ab3a85cda4a409cabe757d55f891ddb
Source noteuspto-grants-1977_08